Immediate Insulin Initiation for Blood Glucose 492 mg/dL in Outpatient Setting
For an outpatient with blood glucose of 492 mg/dL, immediately initiate a basal-bolus insulin regimen with a total daily dose of 0.4-0.5 U/kg body weight: give 50% as basal insulin (glargine, detemir, or degludec) once or twice daily, and 50% as rapid-acting insulin (lispro, aspart, or glulisine) divided equally before three meals, plus correction doses. 1, 2
Rationale for Immediate Insulin
At 492 mg/dL, this patient meets criteria for immediate insulin therapy regardless of prior treatment history. Guidelines consistently recommend starting insulin when blood glucose is ≥300-350 mg/dL, especially if symptomatic 3, 4, 5. This level of hyperglycemia requires rapid correction to prevent acute complications and reduce glucotoxicity.
Specific Insulin Regimen
Calculate Total Daily Dose (TDD)
- For insulin-naive patients: 0.4-0.5 U/kg body weight 1, 2
- Example: For a 70 kg patient = 28-35 units total daily dose
- Use the lower end (0.3-0.4 U/kg) if patient is elderly (>65 years), has renal impairment, or poor oral intake 1
Distribute the Dose
Basal Insulin (50% of TDD):
- Preferred options: Glargine U-100, detemir, or degludec 1, 2
- Give once daily (glargine/degludec) or twice daily (detemir/NPH) 1, 2
- Administer at the same time each day; morning dosing acceptable 6, 7
Rapid-Acting Insulin (50% of TDD):
- Options: Lispro, aspart, or glulisine 1, 2
- Divide equally before three meals (approximately 1/6 of TDD per meal)
- Give immediately before eating 1
Correction (Supplemental) Insulin
Add correction doses using the same rapid-acting insulin 2:
Standard correction scale (adjust based on insulin sensitivity):
- BG 141-180 mg/dL: 2-4 units
- BG 181-220 mg/dL: 4-6 units
- BG 221-260 mg/dL: 6-8 units
- BG 261-300 mg/dL: 8-10 units
- BG 301-350 mg/dL: 10-12 units
- BG 351-400 mg/dL: 12-14 units
- BG >400 mg/dL: 14-16 units 2
Use the "usual" column for most patients; use "insulin-sensitive" column for elderly, those with renal impairment, or those not eating 2.
Titration Strategy
Adjust every 2-3 days based on fingerstick glucose monitoring 5, 8:
Basal insulin: Titrate based on fasting glucose
Prandial insulin: Titrate based on pre-meal and 2-hour post-meal glucose
Critical Pitfalls to Avoid
Do NOT use sliding scale insulin alone - This approach is condemned in guidelines and leads to persistent hyperglycemia 1, 2. Always use scheduled basal-bolus therapy.
Do NOT delay insulin initiation - At this glucose level, oral agents will not achieve timely control 3, 1
Do NOT use premixed insulin initially - Associated with unacceptably high hypoglycemia rates in hospital settings and less flexibility 1. Basal-bolus offers better control.
Do NOT give rapid-acting insulin at bedtime - Risk of nocturnal hypoglycemia 6, 7
Hold prandial insulin if patient cannot eat - Continue basal insulin but withhold meal-time doses 1, 2
Monitoring Requirements
- Fingerstick glucose: Before each meal and at bedtime initially
- Assess for symptoms: Polyuria, polydipsia, weight loss (suggests possible type 1 diabetes or severe insulin deficiency)
- Check for ketones if symptomatic or if type 1 diabetes suspected
- Follow-up within 2-3 days to assess response and adjust doses 5, 8
Alternative Simplified Approach (If Complexity is Barrier)
If the full basal-bolus regimen is too complex for the patient's self-management abilities, consider a basal-plus approach 1:
- Start basal insulin at 0.2-0.25 U/kg daily
- Add single dose of rapid-acting insulin before largest meal
- Add correction doses as needed
- This reduces injection burden while still providing scheduled insulin coverage
However, given the severity of hyperglycemia (492 mg/dL), the full basal-bolus regimen is strongly preferred for rapid glucose normalization 1, 2.